Literature DB >> 16922873

Differential glutamate dehydrogenase (GDH) activity profile in patients with temporal lobe epilepsy.

Gauri H Malthankar-Phatak1, Nihal de Lanerolle, Tore Eid, Dennis D Spencer, Kevin L Behar, Susan S Spencer, Jung H Kim, James C K Lai.   

Abstract

PURPOSE: Pathophysiologic mechanisms underlying temporal lobe epilepsy (TLE) are still poorly understood. One major hypothesis links alterations in energy metabolism to glutamate excitotoxicity associated with seizures in TLE. The purpose of this study was to determine whether changes in the activities of enzymes critical in energy and neurotransmitter metabolism contributed to the alterations in metabolic status leading to the excitotoxic effects of glutamate.
METHODS: Activities of four key enzymes involved in energy metabolism and glutamate cycling in the brain [aspartate aminotransferase (AAT), citrate synthase (CS), glutamate dehydrogenase (GDH), and lactate dehydrogenase (LDH)] were measured in anterolateral temporal neocortical and hippocampal tissues obtained from three different groups of medically intractable epilepsy patients having either mesial, paradoxical, or mass lesion-associated temporal lobe epilepsy (MTLE, PTLE, MaTLE), respectively.
RESULTS: We found that GDH activity was significantly decreased in the temporal cortex mainly in the MTLE group. A similar trend was recognized in the hippocampus of the MTLE. In all three patient groups, GDH activity was considerably lower, and AAT and LDH activities were higher in cortex of MTLE as compared with the corresponding activities in hippocampus (p<0.05). In the MTLE cortex and hippocampus, GDH activities were negatively correlated with the duration since the first intractable seizure.
CONCLUSIONS: Our results support the hypothesis suggesting major alteration in GDH activity mainly in the MTLE group. It is proposed that significant alterations in the enzyme activities may be contributing to decreased metabolism of glutamate, leading to its accumulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16922873     DOI: 10.1111/j.1528-1167.2006.00543.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  16 in total

Review 1.  Astrocytic regulation of glutamate homeostasis in epilepsy.

Authors:  Douglas A Coulter; Tore Eid
Journal:  Glia       Date:  2012-05-16       Impact factor: 7.452

2.  Changes in the expression of selenoproteins in mesial temporal lobe epilepsy patients.

Authors:  Ayşe Yüzbaşioğlu; Hülya Karataş; Yasemin Gürsoy-Ozdemir; Serap Saygi; Nejat Akalan; Figen Söylemezoğlu; Turgay Dalkara; Y Cetin Kocaefe; Meral Ozgüç
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

Review 3.  Astrocytes and epilepsy.

Authors:  Nihal C de Lanerolle; Tih-Shih Lee; Dennis D Spencer
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 4.  Glutamate dehydrogenase in brain mitochondria: do lipid modifications and transient metabolon formation influence enzyme activity?

Authors:  Mary C McKenna
Journal:  Neurochem Int       Date:  2011-07-13       Impact factor: 3.921

5.  Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.

Authors:  Joshua B Owen; Fabio Di Domenico; Rukhsana Sultana; Marzia Perluigi; Chiara Cini; William M Pierce; D Allan Butterfield
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

Review 6.  Physiological bases of the K+ and the glutamate/GABA hypotheses of epilepsy.

Authors:  Mauro DiNuzzo; Silvia Mangia; Bruno Maraviglia; Federico Giove
Journal:  Epilepsy Res       Date:  2014-04-21       Impact factor: 3.045

7.  Peripherally restricted acute phase response to a viral mimic alters hippocampal gene expression.

Authors:  Lindsay T Michalovicz; Gregory W Konat
Journal:  Metab Brain Dis       Date:  2013-12-24       Impact factor: 3.584

8.  A subconvulsive dose of kainate selectively compromises astrocytic metabolism in the mouse brain in vivo.

Authors:  Anne B Walls; Elvar M Eyjolfsson; Arne Schousboe; Ursula Sonnewald; Helle S Waagepetersen
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-14       Impact factor: 6.200

9.  Glutamate Dehydrogenase-Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction.

Authors:  Sharon S Lander; Usman Khan; Nicole Lewandowski; Darpan Chakraborty; Frank A Provenzano; Susana Mingote; Sergiy Chornyy; Francesca Frigerio; Pierre Maechler; Hanoch Kaphzan; Scott A Small; Stephen Rayport; Inna Gaisler-Salomon
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

10.  Targeting deficiencies in mitochondrial respiratory complex I and functional uncoupling exerts anti-seizure effects in a genetic model of temporal lobe epilepsy and in a model of acute temporal lobe seizures.

Authors:  Kristina A Simeone; Stephanie A Matthews; Kaeli K Samson; Timothy A Simeone
Journal:  Exp Neurol       Date:  2013-11-21       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.